MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-06-0014977
Vvic Pharma Private Limited
Vvic Pharma Private Limited - chemicals in Ankleshwar, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.14 Cr
▲ 303% YoY
Net loss · FY 2025
₹12.23 Lakh
Net margin -3.9%
EBITDA · FY 2025
₹30.39 Lakh
EBITDA margin 9.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹2.85 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Vvic Pharma Private Limited
Data last updated:
Vvic Pharma Private Limited is a private limited company based in Ankleshwar, Gujarat, India. It operates in the chemical products or preparations of a kind used in the textiles segment of the chemicals sector. It was incorporated on 24 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24297GJ2020PTC114955. Its GSTIN is 24AAHCV4903H1ZE (Gujarat).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Jatin Rameshbhai Lathiya and Milan Bharatbhai Lathiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 204 – C/3 GIDC Panoli, Ankleshwar, Gujarat, India – 394116.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.14 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹12.23 Lakh (net margin -3.9%) and EBITDA of ₹30.39 Lakh (EBITDA margin 9.7%).
As per MCA filings, the company has open charges of ₹2.85 Cr on record.
Vvic Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0014977).
Company details
CIN U24297GJ2020PTC114955
Registration Number 114955
Incorporation Date 24 July 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-GJ-06-0014977
Key People
Jatin Rameshbhai Lathiya Director Milan Bharatbhai Lathiya Director Jiteshbhai Manjibhai Lakhani Director Recognitions & Rankings of Vvic Pharma
Contact details
Vvic Pharma Private Limited's registered office is in Ankleshwar, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 204 – C/3 GIDC Panoli, Ankleshwar, Gujarat, India – 394116
- IndustryChemicals, Chemical Products Or Preparations Of A Kind Used In The Textiles, Manufacturing, Other Chemical Product
To see the full contact details of Vvic Pharma Private Limited, buy the company report.
Comprehensive company report
Vvic Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vvic Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vvic Pharma Private Limited, buy the company report.
Financials of Vvic Pharma Private Limited
FY 2025 filings availableVvic Pharma Private Limited reported revenue of ₹3.14 Cr (up 303% YoY) for FY 2025.
Revenue · FY 2025
₹3.14 Cr ▲ 303%
Net loss · FY 2025
₹12.23 Lakh margin -3.9%
EBITDA · FY 2025
₹30.39 Lakh margin 9.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 303%
EBITDA CAGR growth
1 year
▲ 9%
Revenue rose 303% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.7% | ||||
| Net Profit Margin | -3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vvic Pharma Private Limited, buy the company report.
Board of directors of Vvic Pharma Private Limited
Vvic Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jatin Rameshbhai Lathiya | Director | 24 Jul 2020 | 6 Years 2 Months | Current |
| Milan Bharatbhai Lathiya | Director | 24 Jul 2020 | 6 Years 2 Months | Current |
| Jiteshbhai Manjibhai Lakhani | Director | 24 Jul 2020 | 6 Years 2 Months | Current |
Peer comparison
Vvic Pharma Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abhelfen Life Science Private Limited | ₹3.23 Cr (FY 2025) | 404.0% | Gandhinagar, Gujarat, India | |||
| Maruti Futuristic Pharma Private Limited | ₹3.2 Cr (FY 2025) | -25.0% | Bangalore, Karnataka, India | |||
| Mekanar Pharma Private Limited | ₹3.2 Cr (FY 2025) | 50.0% | Hyderabad, Telangana, India | |||
| Cil Laboratories Private Limited | ₹3.14 Cr (FY 2023) | 26590.0% | Kolkata, West Bengal, India | |||
| Vvic Pharma Private Limitedthis company | ₹3.14 Cr (FY 2025) | -₹12.23 Lakh | -3.9% | 303.0% | Ankleshwar, Gujarat, India | |
| Sthree Chemicals Private Limited | ₹3.11 Cr (FY 2024) | -53.0% | Walajapet, Tamil Nadu, India | |||
| Supreme Drugs Private Limited | ₹3.08 Cr (FY 2024) | 1350.0% | Banaskatha, Gujarat, India | |||
| Innosyn Life Sciences Private Limited | ₹3.04 Cr (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Nic Bioscience Private Limited | ₹3.03 Cr (FY 2025) | 17.0% | Ankleshwar, Gujarat, India | |||
| Vandana Life Sciences Private Limited | ₹2.82 Cr (FY 2025) | -54.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Vvic Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.85 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Nov 2022 | 100645817 | Others | ₹2.85 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Vvic Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vvic Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vvic Pharma Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
Active EPFO establishments
1
GST
Vvic Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCV4903H1ZE | Gujarat | Active | 27 Jul 2020 |
To see the full GST registrations and return filing status of Vvic Pharma Private Limited, buy the company report.
Recent activity
Vvic Pharma Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Hareshkumar Nanjibhai Lathiya ceased to be Director on 13 Feb 2023.
AGM
Vvic Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vvic Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Hareshkumar Nanjibhai Lathiya ceased to be Director.
Ceased
Rohitkumar Bhagwanbhai Dholakia ceased to be Director.
Charges
A charge with Others amounted to Rs. 2.85 Cr with Charge ID 100645817 was registered on 07 Nov 2022.
Appointed
Jatin Rameshbhai Lathiya was appointed as Director.
Appointed
Jiteshbhai Manjibhai Lakhani was appointed as Director.
Appointed
Milan Bharatbhai Lathiya was appointed as Director.
Incorporation
24 Jul 2020
Vvic Pharma Private Limited was registered on 24 Jul 2020 with Roc Ahmedabad & aged 6 years 3 months as per MCA records.
Frequently asked questions
Vvic Pharma is an active private limited company based in Ankleshwar, Gujarat, India. The company works in chemical products or preparations of a kind used in the textiles, within the chemicals industry. It was incorporated on 24 July 2020 (6+ years old) and is registered under CIN U24297GJ2020PTC114955.
Vvic Pharma has 3 current directors:
- Jatin Rameshbhai Lathiya - Director
- Milan Bharatbhai Lathiya - Director
- Jiteshbhai Manjibhai Lakhani - Director
The latest financial statements of Vvic Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Vvic Pharma is 24AAHCV4903H1ZE, registered in Gujarat.
The CIN (Corporate Identification Number) of Vvic Pharma is U24297GJ2020PTC114955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vvic Pharma was incorporated on 24 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Vvic Pharma by revenue are Abhelfen Life Science Private Limited, Maruti Futuristic Pharma Private Limited, Mekanar Pharma Private Limited, Cil Laboratories Private Limited, Sthree Chemicals Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hareshkumar Nanjibhai Lathiya ceased to be Director on 13 Feb 2023. Rohitkumar Bhagwanbhai Dholakia ceased to be Director on 13 Feb 2023. Jatin Rameshbhai Lathiya was appointed as Director on 24 Jul 2020. Vvic Pharma has 5 board changes on record in total.
Yes, Vvic Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-06-0014977).
The registered office of Vvic Pharma is at Plot No 204 – C3 GIDC Panoli, Ankleshwar, Gujarat, India – 394116.
Vvic Pharma operates in the chemicals industry, in the chemical products or preparations of a kind used in the textiles segment.